GMED
Price
$58.82
Change
+$0.63 (+1.08%)
Updated
Jun 26 closing price
Capitalization
7.19B
34 days until earnings call
SENS
Price
$0.50
Change
-$0.00 (-0.00%)
Updated
Jun 26 closing price
Capitalization
281.84M
41 days until earnings call
Interact to see
Advertisement

GMED vs SENS

Header iconGMED vs SENS Comparison
Open Charts GMED vs SENSBanner chart's image
Globus Medical
Price$58.82
Change+$0.63 (+1.08%)
Volume$1.3M
Capitalization7.19B
Senseonics Holdings
Price$0.50
Change-$0.00 (-0.00%)
Volume$6.97M
Capitalization281.84M
GMED vs SENS Comparison Chart in %
Loading...
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMED vs. SENS commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongBuy and SENS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (GMED: $58.82 vs. SENS: $0.50)
Brand notoriety: GMED and SENS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GMED: 85% vs. SENS: 119%
Market capitalization -- GMED: $7.19B vs. SENS: $281.84M
GMED [@Medical Specialties] is valued at $7.19B. SENS’s [@Medical Specialties] market capitalization is $281.84M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 0 FA rating(s) are green whileSENS’s FA Score has 1 green FA rating(s).

  • GMED’s FA Score: 0 green, 5 red.
  • SENS’s FA Score: 1 green, 4 red.
According to our system of comparison, SENS is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 4 TA indicator(s) are bullish while SENS’s TA Score has 5 bullish TA indicator(s).

  • GMED’s TA Score: 4 bullish, 3 bearish.
  • SENS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SENS is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical Specialties) experienced а +2.53% price change this week, while SENS (@Medical Specialties) price change was -1.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.86%. For the same industry, the average monthly price growth was +1.14%, and the average quarterly price growth was -0.24%.

Reported Earning Dates

GMED is expected to report earnings on Jul 31, 2025.

SENS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMED($7.19B) has a higher market cap than SENS($282M). GMED has higher P/E ratio than SENS: GMED (49.65) vs SENS (8.58). SENS YTD gains are higher at: -4.471 vs. GMED (-28.884). GMED has higher annual earnings (EBITDA): 347M vs. SENS (-48.01M). GMED has more cash in the bank: 518M vs. SENS (109M). SENS has less debt than GMED: SENS (47.8M) vs GMED (520M). GMED has higher revenues than SENS: GMED (1.57B) vs SENS (22.4M).
GMEDSENSGMED / SENS
Capitalization7.19B282M2,550%
EBITDA347M-48.01M-723%
Gain YTD-28.884-4.471646%
P/E Ratio49.658.58578%
Revenue1.57B22.4M7,000%
Total Cash518M109M475%
Total Debt520M47.8M1,088%
FUNDAMENTALS RATINGS
GMED vs SENS: Fundamental Ratings
GMED
SENS
OUTLOOK RATING
1..100
575
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
8898
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
8362
P/E GROWTH RATING
1..100
9829
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SENS's Valuation (59) in the Electronic Components industry is in the same range as GMED (79) in the Medical Specialties industry. This means that SENS’s stock grew similarly to GMED’s over the last 12 months.

GMED's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as SENS (98) in the Electronic Components industry. This means that GMED’s stock grew similarly to SENS’s over the last 12 months.

GMED's SMR Rating (84) in the Medical Specialties industry is in the same range as SENS (100) in the Electronic Components industry. This means that GMED’s stock grew similarly to SENS’s over the last 12 months.

SENS's Price Growth Rating (62) in the Electronic Components industry is in the same range as GMED (83) in the Medical Specialties industry. This means that SENS’s stock grew similarly to GMED’s over the last 12 months.

SENS's P/E Growth Rating (29) in the Electronic Components industry is significantly better than the same rating for GMED (98) in the Medical Specialties industry. This means that SENS’s stock grew significantly faster than GMED’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDSENS
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
66%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
57%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
53%
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GMED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SENS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BBTLX15.320.14
+0.92%
Bridge Builder Tax Managed Large Cap
DWOAX19.15N/A
N/A
BNY Mellon Research Growth A
TPLNX18.36N/A
N/A
Timothy Plan Small Cap Value A
FDKFX15.36N/A
N/A
Fidelity International Discovery K6
CNREX23.03N/A
N/A
Commonwealth Real Estate Securities

SENS and

Correlation & Price change

A.I.dvisor tells us that SENS and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SENS and ARAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SENS
1D Price
Change %
SENS100%
-0.28%
ARAY - SENS
31%
Poorly correlated
-1.49%
NAOV - SENS
31%
Poorly correlated
-1.07%
ICCM - SENS
28%
Poorly correlated
-0.49%
GMED - SENS
28%
Poorly correlated
+1.08%
OSUR - SENS
27%
Poorly correlated
+5.23%
More